Viewing Study NCT03201458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-05-30 @ 9:50 AM
Study NCT ID: NCT03201458
Status: COMPLETED
Last Update Posted: 2024-04-05
First Post: 2017-06-27
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gallbladder Carcinoma View
None Metastatic Cholangiocarcinoma View
None Stage III Intrahepatic Cholangiocarcinoma AJCC v8 View
None Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 View
None Unresectable Cholangiocarcinoma View
Keywords: